Will Innovations in Biomarkers Lead to a Paradigm Shift in Drug Discovery?
With the new avenues in ‘omics’ technology, biomarkers are now being applied to optimize therapies
03-Jul-2014 -
With the efficacy for most drugs targeting severe therapeutic indications ranging from a meagre 25 percent to 50 percent, there is a tremendous market for biomarkers. Thus far, drugs have been administered without knowing if they will work for a specific patient. Biomarkers are now being used in ...
biomarkers
drug development
Frost & Sullivan
+6